[HTML][HTML] Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study
A Nel, N Van Niekerk, B Van Baelen, M Malherbe… - The Lancet …, 2021 - thelancet.com
Summary Background The Ring Study, a phase 3 trial in 1959 sexually active women
(randomised 2: 1), showed a favourable safety profile and a 31% HIV-1 infection risk …
(randomised 2: 1), showed a favourable safety profile and a 31% HIV-1 infection risk …
HIV-positive–to–HIV-positive kidney transplantation—results at 3 to 5 years
Background The outcome of kidney transplantation in human immunodeficiency virus (HIV)–
positive patients who receive organs from HIV-negative donors has been reported to be …
positive patients who receive organs from HIV-negative donors has been reported to be …
HIV-positive kidney donor selection for HIV-positive transplant recipients
The risks associated with transplanting HIV-positive kidneys into HIV-positive recipients
have not been well studied. Since 2008, 43 kidneys from 25 HIV-positive deceased donors …
have not been well studied. Since 2008, 43 kidneys from 25 HIV-positive deceased donors …
[HTML][HTML] Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis
B Chimukangara, RJ Lessells, SY Rhee… - …, 2019 - thelancet.com
Abstract Background South Africa has the largest public antiretroviral therapy (ART)
programme in the world. We assessed temporal trends in pretreatment HIV-1 drug …
programme in the world. We assessed temporal trends in pretreatment HIV-1 drug …
[HTML][HTML] Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview
PO Bessong, ND Matume, DM Tebit - AIDS Research and Therapy, 2021 - Springer
Abstract Background South Africa, with one of the highest HIV prevalences in the world,
introduced the universal test and treat (UTT) programme in September 2016. Barriers to …
introduced the universal test and treat (UTT) programme in September 2016. Barriers to …
[HTML][HTML] Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the first South African National Survey
K Steegen, S Carmona, M Bronze… - PloS one, 2016 - journals.plos.org
Background In order to assess the level of transmitted and/or pre-treatment antiretroviral
drug resistance to HIV-1, the World Health Organization (WHO) recommends that regular …
drug resistance to HIV-1, the World Health Organization (WHO) recommends that regular …
[HTML][HTML] Outcome of patients on second line antiretroviral therapy under programmatic condition in India
J Chakravarty, S Sundar, A Chourasia, PN Singh… - BMC infectious …, 2015 - Springer
Abstract Background The National AIDS Control Organization of India has been providing
free second line antiretroviral therapy (ART) since 2008. This observational study reports the …
free second line antiretroviral therapy (ART) since 2008. This observational study reports the …
An affordable HIV-1 drug resistance monitoring method for resource limited settings
J Manasa, S Danaviah, S Pillay, P Padayachee… - JoVE (Journal of …, 2014 - jove.com
HIV-1 drug resistance has the potential to seriously compromise the effectiveness and
impact of antiretroviral therapy (ART). As ART programs in sub-Saharan Africa continue to …
impact of antiretroviral therapy (ART). As ART programs in sub-Saharan Africa continue to …
[HTML][HTML] Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia
Objectives The aim of this study was to evaluate HIV-1 drug resistance among patients
failing first-line antiretroviral therapy in Ethiopia. Methods A total of 699 adults infected with …
failing first-line antiretroviral therapy in Ethiopia. Methods A total of 699 adults infected with …
[HTML][HTML] Immunological and molecular assessment of HIV-1 mutations for antiretroviral drug resistance in Saudi Arabia
MM El-Daly, KA Zaher, EA Zaki, LH Bajrai, MM Alhazmi… - Plos one, 2024 - journals.plos.org
Human Immunodeficiency Virus (HIV) is a significant threat to public health. HIV genotyping
and antiretroviral resistance testing may have contributed to improved non-treated …
and antiretroviral resistance testing may have contributed to improved non-treated …